Opinion · 22 Oct 2024
ArticlePublished 2014
A Liquid Chromatography Tandem Mass Spectrometry based method for the Simultaneous Determination of Irbesartan and Hydrochlorothiazide in Human Plasma
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The aim of current study was to develop and validate a rapid, explicit and vigorous assay based on solid phase extraction and liquid chromatographyelectrospray ionization tandem mass spectrometry (LC-ESI MS-MS) for the simultaneous quantitative analysis of Irbesartan and Hydrochlorothiazide in human plasma using Losartan and Hydroflumethiazide as internal standards (IS). The precursor to product ion transitions of m/z 427.3/ 193.0 and m/z 295.8/ 205.1 were used to measure the Irbesartan and Hydrochlorothiazide respectively. The method was validated over a concentration range of 99.9 to 6274.0 ng mL-1 for Irbesartan and 3.18 to 500.45 ng mL-1 for Hydrochlorothiazide. The method was validated over the parameters like selectivity, matrix effect, sensitivity, linearity, precision and accuracy various stabilities (bench top stability, standard stock solution stability, stock dilution stability, auto sampler stability, freeze thaw stability, long term stability), effect of potentially interfering drugs, dilution integrity, recovery and reinjection reproducibility. The mean % recovery of Irbesartan, Hydrochlorothiazide, Losartan and Hydroflumethiazide were 89.03 %, 83.15 %, 88.89 % and 84.89 % with a precision of 9.39 %, 2.79 %, 4.36 % and 2.12 % respectively. The RSD % of intra-day and inter-day assay was ≤15%. The application of this assay was demonstrated in a bioequivalence study after an oral administration of a tablet containing higher dose of Hydrochlorothiazide and Irbesartan in healthy volunteers.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in International Journal of Drug Development and Research.
Opinion · 22 Oct 2024
From Monoclonal Antibodies to CAR-T Therapy: Trends and Transformations in Cancer Treatment
Perspective · 21 Oct 2024
Natural Products in Drug Discovery: From Traditional Remedies to Modern Medicines
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Drug Development and Research
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Peeyush Jain”
- BylineArticles whose byline prints “Yashumati R Bhardwaj”
- BylineArticles whose byline prints “Dharma Kishore”
